Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07620522 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Observational Study of RHINOSEDAL in Acute Nasal Obstruction

Study acronym: RHINOSEDAL
StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This prospective, multicenter, national, observational, non-interventional post-market clinical follow-up study evaluates the performance and safety of RHINOSEDAL in children and adults presenting with acute nasal obstruction associated with common cold, allergic or non-allergic rhinitis, or rhinosinusitis. Patients prescribed RHINOSEDAL in routine care will be followed for 6 ±1 days using patient-reported outcome measures including the NOSE score.
Trial Details
NCT Number NCT07620522
Lead Sponsor Laboratoires Elerte
Collaborators: Clin-Experts
Conditions
(from sponsor)		 Nasal Obstruction, Common Cold, Allergic Rhinitis, Non-allergic Rhinitis, Rhinosinusitis
Related terms Common Cold, Nasal Obstruction, Rhinitis, Rhinitis, Allergic, Rhinosinusitis
Enrollment 126 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov